Immunotherapy: DMMR Presents Opportunities to Enhance Immunotherapy

Overview

Journal Nat Rev Clin Oncol

Specialty Oncology

Date 2017 Dec 20

PMID 29255235

Citations 4

Authors

David Killock

Affiliations

Soon will be listed here.

Citing Articles

Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapy.

Ji Z, Wang X, Xin J, Ma L, Zuo D, Li H J Immunother Cancer. 2024; 12(12).

PMID: 39653554 PMC: 11629098. DOI: 10.1136/jitc-2024-010041.

Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.

Zhu M, Wang X, Zhang Q, Xie C, Wang T, Shen K Aging (Albany NY). 2024; 16(3):2563-2590.

PMID: 38315450 PMC: 10911359. DOI: 10.18632/aging.205498.

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors.

He J, Zhou X, Wang X, Zhang Q, Zhang L, Wang T Int J Gen Med. 2022; 15:8257-8274.

PMID: 36438022 PMC: 9698365. DOI: 10.2147/IJGM.S389275.

Prognostic value and immunological role of FOXM1 in human solid tumors.

Wei G, Yang X, Lu H, Zhang L, Wei Y, Li H Aging (Albany NY). 2022; 14(22):9128-9148.

PMID: 36435510 PMC: 9740373. DOI: 10.18632/aging.204394.

References

Germano G, Lamba S, Rospo G, Barault L, Magri A, Maione F . Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth. Nature. 2017; 552(7683):116-120. DOI: 10.1038/nature24673. View